Minor Complication Rates Higher Among Black Patients After Bariatric Procedures

Bariatric surgery linked to lower risk of psychiatric disorders than GLP-1 drugs

People who have metabolic and bariatric surgery are significantly less likely to develop psychiatric disorders compared to those who take weekly injections of GLP-1 anti-obesity medications, according to a new study presented today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2025 Annual Scientific Meeting.

Surgery Still Beats Ozempic and Other GLP-1 Drugs in Real-World Weight Loss Study

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

Study suggests surgery more effective than Ozempic to lose weight

Researchers found after bariatric procedures, patients lost an average of 58 pounds after two years, compared to 12 pounds for patients who received a GLP-1 prescription.

Ozempic could do what health advocates couldn’t

For the first time in modern history, a pharmaceutical — not a food trend — is rewriting the rules of how, when, and why we eat.

Ozempic can make some people lose weight without them even taking it

Families of those administering the drug are discovering a surprising side effect: they are changing their relationship with food.

What to know about “Ozempic face”

This popular drug is getting flack for causing facial changes, but any type of rapid weight loss can produce similar effects. Get the details. By: Elizabeth Millard Medical Reviewer Rodrigo Barros, M.D., Ph.D. If you’re considering taking Ozempic (semaglutide) for type 2 diabetes management or Wegovy (also semaglutide) for weight loss, you may have concerns about what’s being called […]